Skip to content

Clinical trials

Phase 4 Schizophrenia trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Phase: Phase 4 Country / region: Taiwan Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20031
20063
20076
20082
20092
20101
20122
20131
20151
20161
20171
20181
20191

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Terminated4
Unknown status4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Taiwan University Hospital5
Kaohsiung Kai-Suan Psychiatric Hospital3
Johnson & Johnson Taiwan Ltd2
Taichung Veterans General Hospital2
Yu-Li Hospital2
Astellas Pharma Inc1
Chang Gung Memorial Hospital1
Janssen Research & Development, LLC1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia24
Psychotic Disorders8
Metabolic Syndrome3
Basal Ganglia Diseases1
Bipolar Disorder1
Central Nervous System Diseases1
Cognitive Dysfunction1
Tardive Dyskinesia1
Tobacco Use Disorder1

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.